Monde Muyoyeta

Monde Muyoyeta

Director of TB Programmes

CIDRZ, Zambia

Email: Monde.Muyoyeta@cidrz.org

 

 

 

 

VALIDATE Role:

Network Investigator

 

Research Keywords: 

TB/HIV, HIV, clinical trials, Implementation research, TB diagnosis

 

Biography:

Current research activities: TB vaccine clinical trial, HIV vaccine Clinical trial, implementation research for enhanced TB case finding, evaluation of Xpert ultra and computer aided diagnosis for digital chest x-rays. Areas of Interest: Clinical trials; Implementation science, Impact Evaluation, Evaluation of new diagnostics, surveys, randomized controlled trials, TB/HIV prevention in prison settings, programmatic management of TB/HIV and MDR TB.

 

Related Websites: 

Profile page at CIDRZ

Profile page at LinkedIn

 

Key Publications:

Point-of-Care Urine Ethyl Glucuronide Testing to Detect Alcohol Use Among HIV-Hepatitis B Virus Coinfected Adults in Zambia. Vinikoor MJ, Zyambo Z, Muyoyeta M, Chander G, Saag MS, Cropsey K. AIDS Behav. 2018 Jan 15. doi: 10.1007/s10461-018-2030-8. [Epub ahead of print]

Digital CXR with computer aided diagnosis versus symptom screen to define presumptive tuberculosis among household contacts and impact on tuberculosis diagnosis. Muyoyeta M, Kasese NC, Milimo D, Mushanga I, Ndhlovu M, Kapata N, Moyo-Chilufya M, Ayles H. BMC Infect Dis. 2017 Apr 24;17(1):301. doi: 10.1186/s12879-017-2388-7.

Age- and Sex-Specific Social Contact Patterns and Incidence of Mycobacterium tuberculosis Infection.Dodd PJ, Looker C, Plumb ID, Bond V, Schaap A, Shanaube K, Muyoyeta M, Vynnycky E, Godfrey-Faussett P, Corbett EL, Beyers N, Ayles H, White RG. Am J Epidemiol. 2016 Jan 15;183(2):156-66. doi: 10.1093/aje/kwv160. Epub 2015 Dec 8.

The Second Zambian National Tuberculosis Drug Resistance survey - a comparison of conventional and molecular methods. Kapata N, Mbulo G, Cobelens F, de Haas P, Schaap A, Mwamba P, Mwanza W, Muvwimi M, Muyoyeta M, Moyo M, Mulenga L, Grobusch MP, Godfrey-Faussett P, Ayles H. Trop Med Int Health. 2015 Nov;20(11):1492-1500. doi: 10.1111/tmi.12581. Epub 2015 Aug 27.

Implementation Research to Inform the Use of Xpert MTB/RIF in Primary Health Care Facilities in High TB and HIV Settings in Resource Constrained Settings. Muyoyeta M, Moyo M, Kasese N, Ndhlovu M, Milimo D, Mwanza W, Kapata N, Schaap A, Godfrey Faussett P, Ayles H. PLoS One. 2015 Jun 1;10(6):e0126376. doi: 10.1371/journal.pone.0126376. eCollection 2015. Erratum in: PLoS One. 2015;10(9):e0137934.

The sensitivity and specificity of using a computer aided diagnosis program for automatically scoring chest X-rays of presumptive TB patients compared with Xpert MTB/RIF in Lusaka Zambia. Muyoyeta M, Maduskar P, Moyo M, Kasese N, Milimo D, Spooner R, Kapata N, Hogeweg L, van Ginneken B, Ayles H. PLoS One. 2014 Apr 4;9(4):e93757. doi: 10.1371/journal.pone.0093757. eCollection 2014.

Detection of tuberculosis using digital chest radiography: automated reading vs. interpretation by clinical officers. Maduskar P, Muyoyeta M, Ayles H, Hogeweg L, Peters-Bax L, van Ginneken B. Int J Tuberc Lung Dis. 2013 Dec;17(12):1613-20. doi: 10.5588/ijtld.13.0325.

Sensitivity, specificity, and reproducibility of the Capilia TB-Neo assay. Muyoyeta M, Mwanza WC, Kasese N, Cheeba-Lengwe M, Moyo M, Kaluba-Milimo D, Ayles H. J Clin Microbiol. 2013 Dec;51(12):4237-9. doi: 10.1128/JCM.02441-13. Epub 2013 Oct 9.

Effect of household and community interventions on the burden of tuberculosis in southern Africa: the ZAMSTAR community-randomised trial. Ayles H, Muyoyeta M, Du Toit E, Schaap A, Floyd S, Simwinga M, Shanaube K, Chishinga N, Bond V, Dunbar R, De Haas P, James A, Gey van Pittius NC, Claassens M, Fielding K, Fenty J, Sismanidis C, Hayes RJ, Beyers N, Godfrey-Faussett P; ZAMSTAR team. Lancet. 2013 Oct 5;382(9899):1183-94. doi: 10.1016/S0140-6736(13)61131-9. Epub 2013 Aug 1.

Field comparison of OraQuick ADVANCE Rapid HIV-1/2 antibody test and two blood-based rapid HIV antibody tests in Zambia. Zachary D, Mwenge L, Muyoyeta M, Shanaube K, Schaap A, Bond V, Kosloff B, de Haas P, Ayles H. BMC Infect Dis. 2012 Aug 8;12:183. doi: 10.1186/1471-2334-12-183.

Evaluation of the Capilia TB assay for culture confirmation of Mycobacterium tuberculosis infections in Zambia and South Africa. Muyoyeta M, de Haas PE, Mueller DH, van Helden PD, Mwenge L, Schaap A, Kruger C, Gey van Pittius NC, Lawrence K, Beyers N, Godfrey-Faussett P, Ayles H. J Clin Microbiol. 2010 Oct;48(10):3773-5. doi: 10.1128/JCM.01688-09. Epub 2010 Aug 4.

Comparison of four culture systems for Mycobacterium tuberculosis in the Zambian National Reference Laboratory. Muyoyeta M, Schaap JA, De Haas P, Mwanza W, Muvwimi MW, Godfrey-Faussett P, Ayles H. Int J Tuberc Lung Dis. 2009 Apr;13(4):460-5.

Costs and cost-effectiveness of tuberculosis cultures using solid and liquid media in a developing country. Mueller DH, Mwenge L, Muyoyeta M, Muvwimi MW, Tembwe R, McNerney R, Godfrey-Faussett P, Ayles HM. Int J Tuberc Lung Dis. 2008 Oct;12(10):1196-202.